New England Discovery Partners, a Genesis Drug Discovery and Development (GD3) Company, is a contract research organization (CRO) that specializes in medicinal chemistry, synthetic chemistry and X-ray crystallography. Staffed with experienced pharmaceutical scientists who have managed drug discovery programs from early lead identification to clinical development, NEDP provides a wide range of drug discovery services to academic investigators and pharmaceutical and biotechnology companies.